158 related articles for article (PubMed ID: 22531718)
1. Gamma-glutamyl transferase: risk and prognosis of cancer.
Fentiman IS
Br J Cancer; 2012 Apr; 106(9):1467-8. PubMed ID: 22531718
[No Abstract] [Full Text] [Related]
2. Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.
Seebacher V; Polterauer S; Grimm C; Rahhal J; Hofstetter G; Bauer EM; Husslein H; Leipold H; Marth C; Reinthaller A; Concin N
Br J Cancer; 2012 Apr; 106(9):1551-5. PubMed ID: 22315051
[TBL] [Abstract][Full Text] [Related]
3. USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.
Vogel RI; Pulver T; Heilmann W; Mooneyham A; Mullany S; Zhao X; Shahi M; Richter J; Klein M; Chen L; Ding R; Konecny G; Kommoss S; Winterhoff B; Ghebre R; Bazzaro M
Oncotarget; 2016 May; 7(21):30962-76. PubMed ID: 27121063
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-related gamma-glutamyl transferase in laboratory or clinical diagnosis of hepatocellular carcinoma.
Yao DF; Dong ZZ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):9-11. PubMed ID: 17287158
[No Abstract] [Full Text] [Related]
5. γ-Glutamyl transferase and its role as a biomarker of systemic malignancies other than hepatocellular carcinomas.
Kapoor S
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):387. PubMed ID: 23348021
[No Abstract] [Full Text] [Related]
6. Increasing serum gamma-glutamyltransferase level accompanies a rapid increase in the incidence of endometrial cancer in Korea: A nationwide cohort study.
Han Y; Park IS; Kim SI; Wang W; Yoo J; Jo H; Lee J; Seol A; Han KD; Song YS
Gynecol Oncol; 2021 Jun; 161(3):864-870. PubMed ID: 33795129
[TBL] [Abstract][Full Text] [Related]
7. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
[TBL] [Abstract][Full Text] [Related]
8. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
9. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
10. Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.
Hashiguchi Y; Kasai M; Fukuda T; Ichimura T; Yasui T; Sumi T
Pathol Oncol Res; 2016 Jul; 22(3):501-4. PubMed ID: 26678075
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer.
Bozkaya Y; Yazıcı O
Expert Rev Mol Diagn; 2019 Mar; 19(3):267-272. PubMed ID: 30722710
[TBL] [Abstract][Full Text] [Related]
12. Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas.
Miyamoto M; Takano M; Tsuda H; Soyama H; Aoyama T; Ishibashi H; Kato K; Iwahashi H; Matuura H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
Oncology; 2017; 93(1):29-35. PubMed ID: 28259868
[TBL] [Abstract][Full Text] [Related]
13. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
[TBL] [Abstract][Full Text] [Related]
14. Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy.
Ikeda Y; Oda K; Ishihara H; Wada-Hiraike O; Miyasaka A; Kashiyama T; Inaba K; Fukuda T; Sone K; Matsumoto Y; Arimoto T; Maeda D; Ikemura M; Fukayama M; Kawana K; Yano T; Aoki D; Osuga Y; Fujii T
Br J Cancer; 2015 Nov; 113(10):1477-83. PubMed ID: 26554657
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma.
Sebastiani V; Visca P; Botti C; Santeusanio G; Galati GM; Piccini V; Capezzone de Joannon B; Di Tondo U; Alo PL
Gynecol Oncol; 2004 Jan; 92(1):101-5. PubMed ID: 14751145
[TBL] [Abstract][Full Text] [Related]
17. A profile of serum CA 15-3, carcinoembryonic antigen, alkaline phosphatase, and gamma-glutamyl transferase levels in patients with breast cancer.
Buamah PK; Bent DJ; Bodger WA; Skillen AW
J Surg Oncol; 1993 Jun; 53(2):84-7. PubMed ID: 8099132
[TBL] [Abstract][Full Text] [Related]
18. Uric acid and gamma-glutamyl transferase activity are associated with left ventricular remodeling indices in patients with chronic heart failure.
Radovanovic S; Savic-Radojevic A; Pekmezovic T; Markovic O; Memon L; Jelic S; Simic D; Radic T; Pljesa-Ercegovac M; Simic T
Rev Esp Cardiol (Engl Ed); 2014 Aug; 67(8):632-42. PubMed ID: 25037542
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers and radiological examinations in the follow-up of patients with oral cancer.
Söderholm AL; Lindqvist C; Haglund C
J Craniomaxillofac Surg; 1992 Jul; 20(5):211-5. PubMed ID: 1357004
[TBL] [Abstract][Full Text] [Related]
20. Lactic dehydrogenase. An old enzyme reborn as a cancer marker?
Schwartz MK
Am J Clin Pathol; 1991 Oct; 96(4):441-3. PubMed ID: 1892120
[No Abstract] [Full Text] [Related]
[Next] [New Search]